Phase 3 Attention Deficit Hyperactivity Disorder (ADHD) trials recruiting now

All Attention Deficit Hyperactivity Disorder (ADHD) trials, every phase

Other phases for Attention Deficit Hyperactivity Disorder (ADHD)

Phase 3 Attention Deficit Hyperactivity Disorder (ADHD) trials

• A Long-term Trial of EB-1020 in Adult Patients With ADHD
  NCT06926829 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
  NCT07087327 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 1 location
• A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
  NCT07086313 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 1 location
• Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
  NCT06931080 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.